Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
May 10 2022 - 04:26PM
Edgar (US Regulatory)
|
|
|
|
|
|
|
|
|
Prospectus Supplement No. 3
To Prospectus dated March 28, 2022
|
|
Filed Pursuant to Rule 424(b)(3)
Registration No. 333-252241
|
Clever Leaves Holdings Inc.
Primary Offering of
17,777,361 Common Shares Issuable Upon Exercise of
Warrants
332,961 Common Shares Issuable Upon Conversion of Non-Voting Common
Shares
125,370 Common Shares Issuable Upon Exercise of
Options
Secondary Offering of
3,654,707 Common Shares
4,900,000 Warrants to Purchase Common Shares
4,900,000 Common Shares Issuable upon Exercise of
Warrants
This Prospectus Supplement No. 3 (this “Prospectus Supplement”)
updates, amends and supplements the Prospectus dated March 28, 2022
(the “Prospectus”) of Clever Leaves Holdings Inc., a corporation
organized under the laws of British Columbia, Canada (“we” or the
“Company”), that forms a part of the Company’s Registration
Statement on Form S-1 (File No. 333-252241). This Prospectus
Supplement is being filed to update, amend and supplement certain
information contained in the Prospectus. This Prospectus Supplement
should be read in conjunction with the Prospectus. If there is any
inconsistency between the information in the Prospectus and this
Prospectus Supplement, you should rely on the information in this
Prospectus Supplement.
Investing in our securities involves a high degree of risk. Before
buying any securities, you should carefully read the discussion of
material risks of investing in our securities in “Risk Factors”
beginning on page 9 of the Prospectus.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed on the adequacy or accuracy of the Prospectus
or this Prospectus Supplement. Any representation to the contrary
is a criminal offense.
The date of this Prospectus Supplement is May 10, 2022

EXPLANATORY
NOTE
Clever Leaves Holdings Inc. (“we” or the “Company”) is filing this
Prospectus Supplement to the Prospectus included in the
Registration Statement on Form S-1 (File No. 333-252241), which was
originally filed with the Securities and Exchange Commission on
January 10, 2021, to correct errors in the director compensation
disclosure. We hereby amend the information in the Prospectus under
the section titled “Executive and Director Compensation—Director
Compensation—Director Compensation Table” with the information
provided below.
Director Compensation
Director Compensation Table
The following table sets forth information concerning the
compensation of our non-employee directors for the year ended
December 31, 2021.
|
|
|
|
|
|
|
|
|
|
|
|
Name |
Fees Earned or Paid in Cash ($) |
Stock Awards
($)(1)(2)
|
Total ($) |
Gary M. Julien |
50,000 |
157,996 |
207,996 |
Etienne Deffarges (3) |
50,000 |
157,996 |
207,996 |
Elisabeth DeMarse |
55,000 |
157,996 |
212,996 |
(1) Amounts reflect the full grant-date fair value of stock awards
granted during the applicable year computed in accordance with
Financial Accounting Standards Board ASC Topic 718, rather than the
amounts paid to or realized by the named individual. We provide
information regarding the assumptions used to calculate the value
of all stock awards made to directors in Note 15 to our audited
financial statements included in our Annual Report on Form 10-K for
the fiscal year ended December 31, 2021.
(2) The table below shows the aggregate numbers of unvested
restricted share units and deferred restricted share units held as
of December 31, 2021 by each director who was serving as of
December 31, 2021.
|
|
|
|
|
|
|
|
|
Name |
Number of Unvested Restricted Share Units Outstanding at Fiscal
Year End |
Number of Deferred Restricted Share Units Outstanding at Fiscal
Year End |
Gary M. Julien |
6,469 |
7,000 |
Etienne Deffarges |
6,469 |
- |
Elisabeth DeMarse |
6,469 |
7,000 |
(3) Mr. Deffarges voluntarily resigned from our board of directors
effective as of January 14, 2022.
Except as described above, no other changes have been made to the
Prospectus or the Registration Statement to which it forms a part.
Accordingly, this Prospectus Supplement consists only of the facing
page and this explanatory note. The remainder of the Prospectus is
unchanged and has therefore been omitted.
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
From Feb 2023 to Mar 2023
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
From Mar 2022 to Mar 2023